Blau, Sibel

Ribociclib as first-line therapy for HR-positive, advanced breast cancer

Hortobagyi, G. N., Stemmer, S. M., Burris, H. A., Yap, Y.-S., Sonke, G. S., Paluch-Shimon, S., Campone, M., Blackwell, K. L., André, F., Winer, E. P., et al. (2016) · New England Journal of Medicine

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 2,039

Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA

Lanman, R. B., Mortimer, S. A., Zill, O. A., Sebisanovic, D., Lopez, R., Blau, S., Collisson, E. A., Divers, S. G., Hoon, D. S. B., Kopetz, E. S., et al. (2015) · PLoS ONE

Cancer Genomics and DiagnosticsPrenatal Screening and Diagnostics

Cited by 695

Reducing Cancer Costs Through Symptom Management and Triage Pathways

Barkley, R., Soobader, M.-J., Wang, J., Blau, S., & Page, R. D. (2019) · Journal of Oncology Practice

Economic and Financial Impacts of CancerEmergency and Acute Care Studies

Cited by 25